« Previous
Next »
Titles
- Telehealth MAT1
- The consistently low percentage of Medicare enrollees receiving medication to treat their opioid use disorder remains a concern1
- The risk of misuse and diversion of buprenorphine for opioid use disorder in Medicare Part D continues to appear low: 20221
- Why health plans should go to the "MAT" in the fight against opioid addiction1
